Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Canopy Growth Corporation
  6. News
  7. Summary
    WEED   CA1380351009


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Canopy Growth : eyes U.S. pot market with deal to buy Colo. edibles company Wana Brands

10/14/2021 | 09:50am EST

TORONTOCanopy Growth Corp. is preparing another route into the U.S. cannabis market with a new deal to acquire an edibles company, if Canada's neighbour moves to allow a key pot component.

The Smiths Falls, Ont. cannabis company announced Thursday that it had reached an agreement to buy Boulder, Colo.-based Wana Brands, but only if tetrahydrocannabinol (THC), the main psychoactive component in cannabis, becomes federally permissible in the U.S.

Several U.S. states have legalized recreational cannabis use, but it remains illegal under federal law.

"The right to acquire Wana secures another major, direct pathway into the U.S. THC market upon federal permissibility, and in Canada we'll be adding the top-ranked cannabinoid gummies to our industry-leading house of brands," said Canopy's chief executive David Klein, in a statement.

The U.S. market has become increasingly attractive for Canadian cannabis brands as they eye new opportunities for revenue growth, after two years of layoffs, downsizings and facility closures at large pot producers including Canopy, Aurora Cannabis Inc. and Tilray Inc.

Pot companies are hoping that the U.S. federally legalizes cannabis, so they can quickly build on their experience in the Canadian market across the border.

In anticipation, Tilray purchased enough of U.S. cannabis retailer MedMen Enterprises Inc.'s convertible debt in April to yield a minority stake, when U.S. legalization occurs.

Hexo Corp. recently signed purchase and sale agreements for a 4,645 square-metre (50,000 square-foot) cannabis production facility in Northern Colorado and the company's chief executive said in May that he was considering approaching multi-state operators in the U.S. to partner on Hexo-powered private label brands.

Meanwhile, Canopy has touted its recent acquisitions of Supreme Cannabis Co. Inc. and AV Cannabis Inc. as helpful to a U.S. expansion.

Its also looked to deepen its U.S. presence by launching four sparkling cannabidiol waters under the Quatreau name across the border in March, adding to the roster of Martha Stewart, BioSteel and This Works products Canopy already sells in the U.S.

Thursday's deal will marry Wana's vast experience with gummies, tarts, tinctures and vapes with Canopy's brands including Tweed, Spectrum Therapeutics, Deep Space and Tokyo Smoke.

While Wana makes and sells cannabis gummies in Colorado, it licenses its intellectual property to partners in several other states and in Canada.

Under the agreement, Canopy will make an upfront cash payment of US$297.5 million and acquire three call option agreements to acquire Wana entities Mountain High Products LLC, Wana Wellness LLC and the Cima Group LLC.

Upon the exercise of each call option agreement, Canopy Growth will make a payment equal to 15 per cent of the fair market value of the entity when the option is exercised. Canopy Growth may also make additional deferred payments as of the 2.5 and five-year anniversaries of the upfront payment.

The call option payments and the deferred payments may be made in cash, shares or a combination at Canopy's discretion.

Nancy Whiteman, Wana's chief executive and co-founder, said her company has had many partners over the last 11 years, but "none has felt like the best and right fit" until she signed the Canopy agreement.

"We have long considered what the next phase of our growth might look like, and this deal is not only a great testament to our focus on bottom line growth and fiscal diligence, but also to the value we believe Wana can bring to Canopy and its shareholders now and in the future," she said, in a statement.

This report by The Canadian Press was first Oct. published Oct. 14, 2021.

Companies in this story: (TSX:WEED, TSX:ACB, TSX:HEXO)

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

Stocks mentioned in the article
ChangeLast1st jan.
CANOPY GROWTH CORPORATION -3.24% 12.85 Delayed Quote.-59.32%
TILRAY, INC. -6.18% 8.95 Delayed Quote.15.50%
10:50aOvation Science Develops New High Dose CBD Formulations for Health and Wellness, Beauty..
10:32aHumble & Fume Details Sales and Distribution Partnership with PAX Labs, Inc.
10:18aToronto index turns negative as pot producers weigh
09:10aHumble & Fume, PAX Labs Enter Partnership for PAX-Branded Vape Devices in Canada
08:56aGage Growth Receives DTC Eligibility, Closes Purchase of Sturgis, Mi., Dispensary
12/02Tilray Launches Fast-Acting Medical Cannabis Oral Strips
12/02High Tide Taps Alpine IQ to Manage Loyalty Program
12/02HIGH TIDE BRIEF : Details Partnership With Alpine IQ, a Data and Marketing Solutions Provi..
12/01Zelira Therapeutics Secures Ethics Approval for Phase 2 Trial of Chronic Pain Drug; Sha..
12/01YELLEN : bank access for cannabis firms would aid U.S. tax collections
More news
Analyst Recommendations on CANOPY GROWTH CORPORATION
More recommendations
Sales 2022 579 M 450 M 450 M
Net income 2022 156 M 122 M 122 M
Net Debt 2022 311 M 242 M 242 M
P/E ratio 2022 32,7x
Yield 2022 -
Capitalization 5 229 M 4 084 M 4 068 M
EV / Sales 2022 9,57x
EV / Sales 2023 7,76x
Nbr of Employees 3 259
Free-Float 63,8%
Duration : Period :
Canopy Growth Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANOPY GROWTH CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 21
Last Close Price 12,85 CAD
Average target price 17,11 CAD
Spread / Average Target 33,2%
EPS Revisions
Managers and Directors
Bruce Linton Chairman & Co-Chief Executive Officer
David Eric Klein Chief Executive Officer & Non-Independent Director
Rade Kovacevic President & Chief Product Officer
Mike Lee Chief Financial Officer & Executive Vice President
Judy A. Schmeling Chairman